Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The overall objective of this trial is to demonstrate clinically relevant superior
antidepressant efficacy of the fixed dose combination PNB01 (low dose pipamperone and
citalopram) over reference antidepressant treatment with citalopram alone, and a low dose of
psychoactive pipamperone alone in patients with moderate to severe Major Depressive Disorder.
This study was specifically designed to assess patient related outcome (PRO) parameters using
an Interactive Voice Response System (IVRS) via telephone.